At a glance
ClinicalIndex Comparison RecordN/ACompleted· 254 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation
In Brief
An observational study for Pregnancy; Nutritional Diseases. Completed, enrolled 254 participants across 1 site.
Detailed Summary
The purpose of this study is to learn if participants in the ADORE study (NCT02626299), who took a DHA supplement during pregnancy, see favorable body fat in their infants from birth to 24 months, and if excessive or appropriate weight gain during pregnancy impacts this result.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy; Nutritional Diseases
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 2017
Enrollment StartNov 2017
Primary CompletionAug 2022
TodayJul 2026
First PostedOct 16, 2017
Enrollment StartNov 1, 2017
Primary CompletionAug 31, 2022
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 8.7 years ago